{"denoms":[{"counts":[{"groupId":"BG000","value":"198"},{"groupId":"BG001","value":"198"},{"groupId":"BG002","value":"396"}],"units":"Participants"}],"groups":[{"description":"Participants received enzalutamide 160 mg, self-administered as four 40-mg capsules, once per day by mouth and 1 bicalutamide-placebo capsule in DB phase.","id":"BG000","title":"Enzalutamide"},{"description":"Participants received bicalutamide 50 mg, self-administered as 1 capsule, once per day by mouth and 4 enzalutamide-placebo capsules in DB phase.","id":"BG001","title":"Bicalutamide"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"64"}],"title":"< 65 years"},{"measurements":[{"groupId":"BG000","value":"82"},{"groupId":"BG001","value":"76"},{"groupId":"BG002","value":"158"}],"title":"65-74 years"},{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"174"}],"title":"≥ 75 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"198"},{"groupId":"BG001","value":"198"},{"groupId":"BG002","value":"396"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex/Gender, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"198"},{"groupId":"BG001","value":"198"},{"groupId":"BG002","value":"396"}]}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}